Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke

Hemianopsia, Homonymous Clinical Trial

Official title:
Treatment of Homonymous Visual Loss With Digital Therapeutics, VIVID Brain, Visual Perceptual Learning Device (HOGWAND Trial) : Multi Center, Randomized, Single-blind (Evaluator), Superiority Prove, Prospective Confirmatory Trial

Status Completed

Clinical Trial Summary

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05525949
Study type	Interventional
Source	Nunaps Inc
Contact
Status	Completed
Phase	N/A
Start date	October 19, 2022
Completion date	November 8, 2023

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT00731796` - Testing of a Functional Outcome Measure for Those With Visual Field Defects	N/A
Completed	`NCT04102605` - Visual Perceptual Learning for the Treatment of Visual Field Defect	N/A
Recruiting	`NCT06047717` - Vision Loss Impact on Navigation in Virtual Reality	N/A
Completed	`NCT04230486` - VR System for Cross-modal Rehabilitation of Hemianopia	N/A
Recruiting	`NCT05397873` - Biofeedback for Hemianopia Vision Rehabilitation	N/A
Completed	`NCT06116760` - Anodal tDCS With Compensatory Audio-visual Training for Acquired Visual Field Defects After Brain Injury	N/A